Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$1.05−0.04 (-3.67%)
Close on Nov 13, 2026Market cap $12.96MP/E –Yield –
Pluri cash
Cash and short-term investments held at the end of each period.
Pluri's cash was $8.75M at Sep 30, 2026. For fiscal 2026 it was $8.85M, down 59.6% from the year before. Over ten years it grew -5.6% a year on average. The highest annual figure on record is $88.22M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $8.85M | -59.6% |
| FY2025 | Jun 30, 2025 | $21.91M | -29.0% |
| FY2024 | Jun 30, 2024 | $30.87M | +393.5% |
| FY2023 | Jun 30, 2023 | $6.26M | -45.2% |
| FY2022 | Jun 30, 2022 | $11.41M | -87.1% |
| FY2021 | Jun 30, 2021 | $88.22M | +49.5% |
| FY2020 | Jun 30, 2020 | $58.99M | +137.9% |
| FY2019 | Jun 30, 2019 | $24.80M | -17.1% |
| FY2018 | Jun 30, 2018 | $29.90M | +14.5% |
| FY2017 | Jun 30, 2017 | $26.11M | +66.3% |
| FY2016 | Jun 30, 2016 | $15.69M | -47.3% |
| FY2015 | Jun 30, 2015 | $29.79M | +24.4% |
| FY2014 | Jun 30, 2014 | $23.94M | -40.8% |
| FY2013 | Jun 30, 2013 | $40.46M | +31.4% |
| FY2012 | Jun 30, 2012 | $30.79M | -28.1% |
| FY2011 | Jun 30, 2011 | $42.83M | +2605.6% |
| FY2010 | Jun 30, 2010 | $1.58M | -32.3% |
| FY2009 | Jun 30, 2009 | $2.34M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $8.75M | -46.7% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $8.85M | -59.6% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $10.50M | -61.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $13.65M | -39.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $16.39M | -38.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $21.91M | -29.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $27.47M | +2.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $22.37M | +245.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $26.68M | +407.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $30.87M | +393.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $26.92M | +632.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $6.49M | -26.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $5.25M | -47.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $6.26M | -45.2% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $3.68M | -85.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $8.82M | -87.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $10.03M | -87.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $11.41M | -87.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $24.93M | -66.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $68.85M | +48.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $79.15M | +49.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $88.22M | +49.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $73.89M | +365.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $46.24M | +171.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $53.13M | +172.1% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $58.99M | +137.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $15.88M | +50.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $17.06M | +16.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $19.52M | -10.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $24.80M | -17.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $10.54M | -68.4% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $14.71M | -58.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $21.72M | +4.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $29.90M | +14.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $33.38M | +2.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $35.29M | +65.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $20.75M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $26.11M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $32.49M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $21.37M | – |
See a number that looks wrong?